SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | n/a |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 2.87 |
| Book Value / Share | 0.02 |
| Price / Book | n/a |
| NCAV ($M) | -18.54 |
| NCAV / Share | -0.14 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -11.25 |
| Return on Assets (ROA) | -0.78 |
| Return on Equity (ROE) | -1.02 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.72 |
| Current Ratio | 0.72 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 29.15 |
| Assets | 50.56 |
| Liabilities | 47.69 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 4.20 |
| Operating Income | -116.50 |
| Net Income | -113.90 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -104.50 |
| Cash from Investing | -0.80 |
| Cash from Financing | 0.60 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| CVSI – CV Sciences, Inc. | CYAN – Cyanotech Corporation |
| CYDY – CytoDyn Inc. | DMKPQ – DMK Pharmaceuticals Corporation |
| DRNK – NOHO, Inc. |
Financial data and stock pages provided by
Fintel.io